1 |
Seydi H, Nouri K, Rezaei N, Tamimi A, Hassan M, Mirzaei H, Vosough M. Autophagy orchestrates resistance in hepatocellular carcinoma cells. Biomed Pharmacother 2023;161:114487. [PMID: 36963361 DOI: 10.1016/j.biopha.2023.114487] [Reference Citation Analysis]
|
2 |
Zhou J, Qiu C, Tang X, Wan R, Wu Z, Zou D, Wang W, Luo Y, Liu T. Investigation of the clinicopathological and prognostic role of circMTO1 in multiple cancers. Expert Rev Mol Diagn 2023;23:159-70. [PMID: 36734331 DOI: 10.1080/14737159.2023.2177102] [Reference Citation Analysis]
|
3 |
Giambra M, Di Cristofori A, Valtorta S, Manfrellotti R, Bigiogera V, Basso G, Moresco RM, Giussani C, Bentivegna A. The peritumoral brain zone in glioblastoma: where we are and where we are going. J Neurosci Res 2023;101:199-216. [PMID: 36300592 DOI: 10.1002/jnr.25134] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
4 |
Chen X, Wei C, Huang L, Syrigos K, Li Y, Li P. Non-coding RNAs regulate mitochondrial dynamics in the development of gastric cancer. Front Mol Biosci 2023;10:1107651. [PMID: 36714260 DOI: 10.3389/fmolb.2023.1107651] [Reference Citation Analysis]
|
5 |
Wu S, Ballah AK, Che W, Wang X. M7G-related LncRNAs: A comprehensive analysis of the prognosis and immunity in glioma. Front Genet 2022;13. [DOI: 10.3389/fgene.2022.961278] [Reference Citation Analysis]
|
6 |
Jafarzadeh A, Noori M, Sarrafzadeh S, Tamehri Zadeh SS, Nemati M, Chatrabnous N, Jafarzadeh S, Hamblin MR, Jafari Najaf Abadi MH, Mirzaei H. MicroRNA-383: A tumor suppressor miRNA in human cancer. Front Cell Dev Biol 2022;10:955486. [DOI: 10.3389/fcell.2022.955486] [Reference Citation Analysis]
|
7 |
Luo K, Liu A, Wu H, Liu Q, Dai J, Liu Y, Wang Z. CircKIF4A promotes glioma growth and temozolomide resistance by accelerating glycolysis. Cell Death Dis 2022;13:740. [PMID: 36030248 DOI: 10.1038/s41419-022-05175-z] [Reference Citation Analysis]
|
8 |
Salinas MD, Valdor R. Chaperone-Mediated Autophagy in Pericytes: A Key Target for the Development of New Treatments against Glioblastoma Progression. IJMS 2022;23:8886. [DOI: 10.3390/ijms23168886] [Reference Citation Analysis]
|
9 |
Jiang Y, Zhao J, Liu Y, Hu J, Gao L, Wang H, Cui D. CircKPNB1 mediates a positive feedback loop and promotes the malignant phenotypes of GSCs via TNF-α/NF-κB signaling. Cell Death Dis 2022;13:697. [PMID: 35945192 DOI: 10.1038/s41419-022-05149-1] [Reference Citation Analysis]
|
10 |
Erfanparast L, Taghizadieh M, Shekarchi AA. Non-Coding RNAs and Oral Cancer: Small Molecules With Big Functions. Front Oncol 2022;12:914593. [DOI: 10.3389/fonc.2022.914593] [Reference Citation Analysis]
|
11 |
Rafiyan M, Abadi MHJN, Zadeh SST, Hamblin MR, Mousavi M, Mirzaei H. Lysophosphatidic Acid Signaling and microRNAs: New Roles in Various Cancers. Front Oncol 2022;12:917471. [DOI: 10.3389/fonc.2022.917471] [Reference Citation Analysis]
|
12 |
Guo S, King P, Liang E, Guo AA, Liu M. LncRNA HOTAIR sponges miR-301a-3p to promote glioblastoma proliferation and invasion through upregulating FOSL1. Cell Signal 2022;94:110306. [PMID: 35292358 DOI: 10.1016/j.cellsig.2022.110306] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
13 |
Ahmadpour S, Taghavi T, Sheida A, Tamehri Zadeh SS, Hamblin MR, Mirzaei H. Effects of microRNAs and long non-coding RNAs on chemotherapy response in glioma. Epigenomics 2022. [PMID: 35473299 DOI: 10.2217/epi-2021-0439] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
14 |
Sadri Nahand J, Salmaninejad A, Mollazadeh S, Tamehri Zadeh SS, Rezaee M, Sheida AH, Sadoughi F, Dana PM, Rafiyan M, Zamani M, Taghavi SP, Dashti F, Mirazimi SMA, Bannazadeh Baghi H, Moghoofei M, Karimzadeh M, Vosough M, Mirzaei H. Virus, Exosome, and MicroRNA: New Insights into Autophagy. Advances in Experimental Medicine and Biology 2022. [DOI: 10.1007/5584_2022_715] [Reference Citation Analysis]
|